The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles

PLoS Pathogens

Volumn 12, Issue 3, 2016, Pages

  Ziegler, Christopher M ^a,b   Eisenhauer, Philip ^a   Bruce, Emily A ^a   Weir, Marion E ^b   King, Benjamin R ^a,b   Klaus, Joseph P ^a,b,c   Krementsov, Dimitry N ^a   Shirley, David J ^a   Ballif, Bryan A ^b   Botten, Jason ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN; MATRIX PROTEIN PPXY; UNCLASSIFIED DRUG; ESCRT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEFECTIVE INTERFERING PARTICLE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TANDEM MASS SPECTROMETRY; VIRAL PLAQUE ASSAY; VIRION; VIROGENESIS; VIRUS LIKE AGENT; VIRUS RECOMBINANT; WESTERN BLOTTING; CELL LINE; ENDOSOME; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; SATELLITE VIRUS; VIRUS RELEASE;

CELL LINE; DEFECTIVE VIRUSES; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; ENDOSOMES; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; VIRION; VIRUS RELEASE;

EID: 84962463355     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005501     Document Type: Article

References (72)

1. Salazar-Bravo J, Ruedas LA, Yates TL, Oldstone MA, Mammalian Reservoirs of Arenaviruses. In: Arenaviruses I. Current Topics in Microbiology and Immunology. 262: SpringerBerlin Heidelberg; 2002. p. 25–63.
2. Buchmeier MJ, de la Torre JC, Peters CJ, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Arenaviridae: The Viruses and Their Replication. In: et al., editors. Fields Virology. 2. 5th ed.Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2007. p. 1791–827.
3. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, et al. Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation. New England Journal of Medicine. 2006;354(21):2235–49. doi: 10.1056/NEJMoa05324016723615.
4. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa Fever. N Engl J Med. 1986;314(1):20–6. doi: 10.1056/NEJM1986010231401043940312.
5. Enria DA, Briggiler AM, Sanchez Z, Treatment of Argentine hemorrhagic fever. Antiviral Res. 2008;78(1):132–9. doi: 10.1016/j.antiviral.2007.10.01018054395.
6. Meyer BJ, De La Torre JC, Southern PJ, Oldstone MA, Arenaviruses: Genomic RNAs, Transcription, and Replication. In: Arenaviruses I. Current Topics in Microbiology and Immunology. 262: SpringerBerlin Heidelberg; 2002. p. 139–57.
7. Rojek JM, Kunz S, Cell entry by human pathogenic arenaviruses. Cellular Microbiology. 2008;10(4):828–35. doi: 10.1111/j.1462-5822.2007.01113.x31228596.
8. Urata S, Yasuda J, Molecular Mechanism of Arenavirus Assembly and Budding. Viruses. 2012;4(10):2049–79. doi: 10.3390/v410204923202453
9. Fehling S, Lennartz F, Strecker T, Multifunctional Nature of the Arenavirus RING Finger Protein Z. Viruses. 2012;4(11):2973–3011. doi: 10.3390/v411297323202512
10. Strecker T, Eichler R, Meulen Jt, Weissenhorn W, Dieter Klenk H, Garten W, et al. Lassa Virus Z Protein Is a Matrix Protein Sufficient for the Release of Virus-Like Particles. J Virol. 2003;77(19):10700–5. doi: 10.1128/jvi.77.19.10700–10705.200312970458
11. Perez M, Craven RC, de la Torre JC, The small RING finger protein Z drives arenavirus budding: Implications for antiviral strategies. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(22):12978–83. doi: 10.1073/pnas.2133782100ISI:000186301100085.
12. Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J, Cellular Factors Required for Lassa Virus Budding. J Virol. 2006;80(8):4191–5. doi: 10.1128/jvi.80.8.4191–4195.200616571837
13. Carlton JG, Martin-Serrano J, Parallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery. Science. 2007;316(5833):1908–12. doi: 10.1126/science.114342217556548
14. Morita E, Sandrin V, Chung H-Y, Morham SG, Gygi SP, Rodesch CK, et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. The EMBO Journal. 2007;26(19):4215–27. doi: 10.1038/sj.emboj.7601850PMC2230844.
15. Hurley JH, ESCRT complexes and the biogenesis of multivesicular bodies. Current opinion in cell biology. 2008;20(1):4–11. doi: 10.1016/j.ceb.2007.12.002PMC2282067.
16. Votteler J, Sundquist Wesley I, Virus Budding and the ESCRT Pathway. Cell Host & Microbe. 2013;14(3):232–41. http://dx.doi.org/10.1016/j.chom.2013.08.012.
17. Huang AS, Baltimore D, Defective Viral Particles and Viral Disease Processes. Nature. 1970;226(5243):325–7. 5439728
18. Huang AS, Defective interfering viruses. Annu Rev Microbiol. 1973;27. 4356530.
19. Meyer BJ, Southern PJ, A novel type of defective viral genome suggests a unique strategy to establish and maintain persistent lymphocytic choriomeningitis virus infections. Journal of Virology. 1997;71(9):6757–64. 9261400
20. Jacobson S, Pfau CJ, Viral pathogenesis and resistance to defective interfering particles. Nature. 1980;283(5744):311–3. 7352005
21. Welsh RM, Pfau CJ, Determinants of Lymphocytic Choriomeningitis Interference. Journal of General Virology. 1972;14(2):177–87. doi: 10.1099/0022-1317-14-2-1774622135
22. Popescu M, Lehmann-Grube F, Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology. 1977;77(1):78–83. Epub 1977/03/01. 841872.
23. Burns JW, Buchmeier MJ, Salvato MS, Glycoproteins of the Arenaviruses. In: The Arenaviridae. The Viruses. New York: Plenum Press; 1993. p. 17–35.
24. Oldstone MB, Viral persistence: mechanisms and consequences. Curr Opin Microbiol. 1998;1(4):436–41. Epub 1999/03/06. 10066504.
25. García M, Cooper A, Shi W, Bornmann W, Carrion R, Kalman D, et al. Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase. Science Translational Medicine. 2012;4(123):123ra24. doi: 10.1126/scitranslmed.300350022378924
26. Pei Z, Harrison MS, Schmitt AP, Parainfluenza Virus 5 M Protein Interaction with Host Protein 14-3-3 Negatively Affects Virus Particle Formation. Journal of Virology. 2011;85(5):2050–9. doi: 10.1128/jvi.02111-1021147917
27. Hemonnot B, Cartier C, Gay B, Rebuffat S, Bardy M, Devaux C, et al. The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6(gag) protein of HIV-1. Journal of Biological Chemistry. 2004;279(31):32426–34. doi: 10.1074/jbc.M313137200ISI:000222849700056.
28. Bajorek M, Caly L, Tran KC, Maertens GN, Tripp RA, Bacharach E, et al. The Thr205 Phosphorylation Site within Respiratory Syncytial Virus Matrix (M) Protein Modulates M Oligomerization and Virus Production. Journal of Virology. 2014;88(11):6380–93. doi: 10.1128/jvi.03856-1324672034
29. Kolesnikova L, Mittler E, Schudt G, Shams-Eldin H, Becker S, Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane. Cellular Microbiology. 2012;14(2):182–97. doi: 10.1111/j.1462-5822.2011.01709.x21981045
30. Perez M, Greenwald DL, de la Torre JC, Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol. 2004;78(20):11443–8. doi: 10.1128/JVI.78.20.11443–11448.200415452271; PubMed Central PMCID: PMCPMC521847.
31. Staneck LD, Trowbridge RS, Welsh RM, Wright EA, Pfau CJ, Arenaviruses: Cellular Response to Long-Term In Vitro Infection with Parana and Lymphocytic Choriomeningitis Viruses. Infection and Immunity. 1972;6(4):444–50. 4564281
32. Popescu M, Schaefer H, Lehmann-Grube F, Homologous interference of lymphocytic choriomeningitis virus: detection and measurement of interference focus-forming units. Journal of Virology. 1976;20(1):1–8. 978787
33. Stocker C, Peralta LM, Kratzberg T, Lohmann F, Bruns M, Characterization of a virus variant produced by L cells persistently infected with lymphocytic choriomeningitis virus. Journal of General Virology. 1994;75(12):3431–9. doi: 10.1099/0022-1317-75-12-3431
34. Welsh RM, Buchmeier MJ, Protein analysis of defective interfering lymphocytic choriomeningitis virus and persistently infected cells. Virology. 1979;96(2). 380148.
35. Peralta LM, Bruns M, Lehmann-Grube F, Biochemical Composition of Lymphocytic Choriomeningitis Virus Interfering Particles. Journal of General Virology. 1981;55(2):475–9. doi: 10.1099/0022-1317-55-2-475
36. Gschwender HH, Popescu M, Rickwood D, Equilibrium Sedimentation of Virus in Density-Gradients of Iodinated Compounds. In: Biological Separations in Iondinated Density-Gradient Media. London: Information Retrieval Ltd.; 1976. p. 145–58.
37. Pedersen IR, Lauffer MA, Bang FB, Maramorosch K, Smith KM, Structural Components and Replication of Arenaviruses. In: Advances in Virus Research. Volume 24: Academic Press; 1979. p. 277–330. 389005
38. Welsh RM, Connell CM, Pfau CJ, Properties of Defective Lymphocytic Choriomeningitis Virus. Journal of General Virology. 1972;17(3):355–9. doi: 10.1099/0022-1317-17-3-3554650728
39. Dutko FJ, Pfau CJ, Arenavirus Defective Interfering Particles Mask the Cell-Killing Potential of Standard Virus. Journal of General Virology. 1978;38(2):195–208. doi: 10.1099/0022-1317-38-2-195627871
40. Lin Y, Kimpler LA, Naismith TV, Lauer JM, Hanson PI, Interaction of the Mammalian Endosomal Sorting Complex Required for Transport (ESCRT) III Protein hSnf7-1 with Itself, Membranes, and the AAA+ ATPase SKD1. Journal of Biological Chemistry. 2005;280(13):12799–809. doi: 10.1074/jbc.M41396820015632132
41. Dalal S, Rosser MFN, Cyr DM, Hanson PI, Distinct Roles for the AAA ATPases NSF and p97 in the Secretory Pathway. Molecular Biology of the Cell. 2004;15(2):637–48. doi: 10.1091/mbc.E03-02-009714617820
42. Taylor GM, Hanson PI, Kielian M, Ubiquitin Depletion and Dominant-Negative VPS4 Inhibit Rhabdovirus Budding without Affecting Alphavirus Budding. Journal of Virology. 2007;81(24):13631–9. doi: 10.1128/jvi.01688-0717913808
43. Pasqual G, Rojek JM, Masin M, Chatton J-Y, Kunz S, Old World Arenaviruses Enter the Host Cell via the Multivesicular Body and Depend on the Endosomal Sorting Complex Required for Transport. PLoS Pathog. 2011;7(9):e1002232. doi: 10.1371/journal.ppat.100223221931550
44. Wirblich C, Tan GS, Papaneri A, Godlewski PJ, Orenstein JM, Harty RN, et al. PPEY Motif within the Rabies Virus (RV) Matrix Protein Is Essential for Efficient Virion Release and RV Pathogenicity. Journal of Virology. 2008;82(19):9730–8. doi: 10.1128/jvi.00889-0818667490
45. Jayakar HR, Murti KG, Whitt MA, Mutations in the PPPY Motif of Vesicular Stomatitis Virus Matrix Protein Reduce Virus Budding by Inhibiting a Late Step in Virion Release. Journal of Virology. 2000;74(21):9818–27. doi: 10.1128/jvi.74.21.9818–9827.200011024108
46. Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, et al. Ebola Virus VP40 Late Domains Are Not Essential for Viral Replication in Cell Culture. Journal of Virology. 2005;79(16):10300–7. doi: 10.1128/jvi.79.16.10300–10307.200516051823
47. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP, Infectivity of Moloney Murine Leukemia Virus Defective in Late Assembly Events Is Restored by Late Assembly Domains of Other Retroviruses. Journal of Virology. 2000;74(16):7250–60. doi: 10.1128/jvi.74.16.7250–7260.200010906179
48. Yasuda J, Hunter E, A Proline-Rich Motif (PPPY) in the Gag Polyprotein of Mason-Pfizer Monkey Virus Plays a Maturation-Independent Role in Virion Release. Journal of Virology. 1998;72(5):4095–103. 9557699
49. Le Blanc I, Prévost M-C, Dokhélar M-C, Rosenberg AR, The PPPY Motif of Human T-Cell Leukemia Virus Type 1 Gag Protein Is Required Early in the Budding Process. Journal of Virology. 2002;76(19):10024–9. doi: 10.1128/jvi.76.19.10024–10029.200212208980
50. Dilley KA, Gregory D, Johnson MC, Vogt VM, An LYPSL Late Domain in the Gag Protein Contributes to the Efficient Release and Replication of Rous Sarcoma Virus. Journal of Virology. 2010;84(13):6276–87. doi: 10.1128/jvi.00238-1020392845
51. Garcia ML, Reynolds TD, Mothes W, Robek MD, Functional Characterization of the Putative Hepatitis B Virus Core Protein Late Domain Using Retrovirus Chimeras. PLoS ONE. 2013;8(8):e72845. doi: 10.1371/journal.pone.007284524009707
52. Wang J, Danzy S, Kumar N, Ly H, Liang Y, Biological Roles and Functional Mechanisms of Arenavirus Z Protein in Viral Replication. Journal of Virology. 2012;86(18):9794–801. doi: 10.1128/jvi.00385-1222761375
53. Urata S, Yasuda J, de la Torre JC, The Z Protein of the New World Arenavirus Tacaribe Virus Has Bona Fide Budding Activity That Does Not Depend on Known Late Domain Motifs. Journal of Virology. 2009;83(23):12651–5. doi: 10.1128/jvi.01012-09ISI:000271465600065.
54. Cornu TI, Feldmann H, de la Torre JC, Cells expressing the RING finger Z protein are resistant to arenavirus infection. Journal of Virology. 2004;78(6):2979–83. doi: 10.1128/jvi.78.6.2979–2983.2004ISI:000220043100032.
55. Wolff S, Ebihara H, Groseth A, Arenavirus budding: a common pathway with mechanistic differences. Viruses. 2013;5(2):528–49. doi: 10.3390/v502052823435234; PubMed Central PMCID: PMCPMC3640512.
56. Obenauer JC, Cantley LC, Yaffe MB, Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 2003;31(13):3635–41. 12824383; PubMed Central PMCID: PMCPMC168990.
57. Wong YH, Lee TY, Liang HK, Huang CM, Wang TY, Yang YH, et al. KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns. Nucleic Acids Res. 2007;35(Web Server issue):W588–94. doi: 10.1093/nar/gkm32217517770; PubMed Central PMCID: PMCPMC1933228.
58. Rauch S, Martin-Serrano J, Multiple Interactions between the ESCRT Machinery and Arrestin-Related Proteins: Implications for PPXY-Dependent Budding. Journal of Virology. 2011;85(7):3546–56. doi: 10.1128/jvi.02045-1021191027
59. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al. Assessment of the Risk of Ebola Virus Transmission from Bodily Fluids and Fomites. Journal of Infectious Diseases. 2007;196(Supplement 2):S142–S7. doi: 10.1086/520545
60. Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. New England Journal of Medicine. 2015;372(25):2423–7. doi: 10.1056/NEJMoa150030625950269.
61. Emond RT, Bannister B, Lloyd G, Southee TJ, Bowen ET, A case of Lassa fever: clinical and virological findings. Br Med J (Clin Res Ed). 1982;285(6347):1001–2. 6812716; PubMed Central PMCID: PMC1500383.
62. Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell. 2003;4(4):263–75. http://dx.doi.org/10.1016/S1535-6108(03)00241-1. 14585354
63. Chosewood LC, Wilson DE, Centers for Disease Control and Prevention (U.S.)National Institutes of Health (U.S.)Biosafety in microbiological and biomedical laboratories. 5th ed.Washington, D.C.: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health; 2009. xxii, 415 p. p.
64. Goñi SE, Iserte JA, Ambrosio AM, Romanowski V, Ghiringhelli PD, Lozano ME, Genomic Features of Attenuated Junín Virus Vaccine Strain Candidate. Virus Genes. 2006;32(1):37–41. doi: 10.1007/s11262-005-5843-216525733
65. Cornillez-Ty CT, Liao L, Yates JR, Kuhn P, Buchmeier MJ, Severe Acute Respiratory Syndrome Coronavirus Nonstructural Protein 2 Interacts with a Host Protein Complex Involved in Mitochondrial Biogenesis and Intracellular Signaling. Journal of Virology. 2009;83(19):10314–8. doi: 10.1128/jvi.00842-0919640993
66. Sanchez AB, De la Torre JC, Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology. 2006;350(2):370–80. doi: 10.1016/j.virol.2006.01.012WOS:000238785900012.
67. Klaus JP, Eisenhauer P, Russo J, Mason AB, Do D, King B, et al. The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles. Cell Host Microbe. 2013;14(5):522–34. Epub 2013/11/19. doi: 10.1016/j.chom.2013.10.01024237698; PubMed Central PMCID: PMCPMC3999090.
68. Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD, Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(12):4663–8. doi: 10.1073/pnas.060065210316537369
69. Burns JW, Buchmeier MJ, Protein-protein interactions in lymphocytic choriomeningitis virus. Virology. 1991;183(2):620–9. doi: 10.1016/0042-6822(91)90991-j1853564
70. Ballif BA, Carey GR, Sunyaev SR, Gygi SP, Large-Scale Identification and Evolution Indexing of Tyrosine Phosphorylation Sites from Murine Brain. Journal of Proteome Research. 2008;7(1):311–8. doi: 10.1021/pr070125418034455
71. Degasperi A, Birtwistle MR, Volinsky N, Rauch J, Kolch W, Kholodenko BN, Evaluating Strategies to Normalise Biological Replicates of Western Blot Data. PLoS ONE. 2014;9(1):e87293. doi: 10.1371/journal.pone.008729324475266
72. Haist K, Ziegler C, Botten J, Strand-Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Measurement of Arenavirus Genomic and Antigenomic RNAs. PLoS ONE. 2015;10(5):e0120043. doi: 10.1371/journal.pone.012004325978311